WOC
VRTX icon

West Oak Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

West Oak Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$19.6K Sell
50
-2
-4% -$836 0.01% 194
2025
Q2 		$22.4K Hold
52
– – 0.01% 206
2025
Q1 		$24.3K Buy
52
+2
+4% +$932 0.01% 207
2024
Q4 		$20.1K Hold
50
– – 0.01% 217
2024
Q3 		$23.3K Hold
50
– – ﹤0.01% 210
2024
Q2 		$23.4K Hold
50
– – 0.01% 211
2024
Q1 		$21K Hold
50
– – 0.01% 207
2023
Q4 		$22K Hold
50
– – 0.01% 207
2023
Q3 		$17K Hold
50
– – 0.01% 213
2023
Q2 		$17.6K Buy
+50
New +$16.8K 0.01% 213

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

West Oak Capital's VRTX Position: Q3 2025 in Review

West Oak Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 3.8% in Q3 2025, selling an estimated $836 and leaving 50 shares worth $19.6K. The position accounts for 0.01% of the portfolio, ranked #194.

West Oak Capital first reported a position in VRTX in Q2 2023 and has held it in 10 quarters since. The position peaked at $24.3K in Q1 2025. 1,521 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • West Oak Capital held 50 shares of Vertex Pharmaceuticals worth $19.6K as of Q3 2025.
  • West Oak Capital sold 2 Vertex Pharmaceuticals shares in Q3 2025, an estimated $836.
  • Vertex Pharmaceuticals made up 0.01% of West Oak Capital's portfolio in Q3 2025, its #194 holding.
  • West Oak Capital first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • West Oak Capital's Vertex Pharmaceuticals position peaked at $24.3K in Q1 2025.
  • 1,521 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on West Oak Capital's 13F filing for Q3 2025, filed 3 Oct 2025.